Clinical Trial Update: Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

The Phase 2 clinical study of SyB L-0501 in patients with indolent B-cell non-Hodgkin's lymphoma and mantle cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• SyB L-0501

Snippet

Sponsor: SymBio Pharmaceuticals | Conditions: Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED